Previous 10 | Next 10 |
SOPHiA GENETICS supports The University of Maryland Medical Center to advance their rare disease research SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that the University of Maryland Medical...
SOPHiA DDM™ for Hereditary Cancers Enables Krsnaa Diagnostics to Expand its NGS Offerings SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Krsnaa Diagnostics, India’s largest ...
SOPHiA DDM TM HRD Solution will help empower clinical researchers to advance cancer research SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Tel Aviv Sourasky Medical Center (Ichilov),...
2023-03-28 09:35:39 ET SOPHiA GENETICS ( NASDAQ: SOPH ) said that Acutis Diagnostics will use SOPHiA DDM to develop a new genomic test. To create the this next-generation sequencing (NGS) test, Acutis will pair SOPHiA DDM for Hereditary Cancers Solution with thei...
The New Assay Will Screen Patients for Clinical Trials and Help Increase Data Analysis for Clinical Researchers SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Acutis Diagnostics, a spec...
2023-03-20 13:07:07 ET Gainers: Loyalty Ventures ( LYLT ) +97% . Ambipar Emergency ( AMBI ) +73% . Lifecore Biomedical ( LFCR ) +60% . InMed Pharmaceuticals ( INM ) +43% . New York Community Bancorp ( NYCB ) +32% . Harbor Cus...
Collaboration provides a solution for a more in-depth analysis of cancer biomarkers SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and the leader in data-driven medicine, is partnering with Agilent to offer a comprehensive solution for cancer ana...
2023-03-07 14:05:05 ET SOPHiA GENETICS SA (SOPH) Q4 2022 Results Earnings Conference Call March 7, 2023, 08:00 AM ET Company Participants Katherine Bailon - Vice President, Investor Relations Jurgi Camblong - Founder and Chief Executive Officer Ross Muken - Senio...
2023-03-07 07:08:08 ET SOPHiA Genetics press release ( NASDAQ: SOPH ): Q4 Non-GAAP EPS of -$0.17 beats by $0.13 . Revenue of $13.38M (+22.3% Y/Y) beats by $0.46M . 2023 Outlook: reported revenue growth expected to be at or above 30%; full year constant ...
Fourth Quarter Revenue Growth Accelerates; Operating Losses Notably Moderate SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced financial results for its fourth quarter and full fiscal year ended December 31, 2022. Recent Hi...
News, Short Squeeze, Breakout and More Instantly...
SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™ Canada NewsWire The hospital will use the SOPHiA DDM™ Platform to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland , July 2...
SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix PR Newswire OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24 , 2024 /PRN...
SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix PR Newswire OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS ® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24, 2024 /...